Products for Research Use Only
RegisterLogin

Moxifloxacin

CAT: 0804-HY-66011A-01Size: 100 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-66011A-01Size:100 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia[1][2].
CAS Number
151096-09-2
Product Name Alternative
BAY 12-8039 (free base)
UNSPSC
12352005
Hazard Statement
H302, H315, H320, H335
Target
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection; Cancer
Assay Protocol
https://www.medchemexpress.com/moxifloxacin.html
Purity
99.72
Solubility
DMSO : 31.25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N(C4)C[C@]5([H])[C@@]4([H])CCCN5)=C3OC)C1=O)O
Molecular Formula
C21H24FN3O4
Molecular Weight
401.43
Precautions
H302, H315, H320, H335
References & Citations
[1]Culley, C.M., et al., Moxifloxacin: clinical efficacy and safety. Am J Health Syst Pharm, 2001. 58 (5) : p. 379-88.|[2]Balfour JA, et al. Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections. Drugs. 2000 Jan;59 (1) :115-39.|[3]Grayo S, et al. Comparison of the in vitro efficacies of moxifloxacin and amoxicillin against Listeria monocytogenes. Antimicrob Agents Chemother. 2008 May;52 (5) :1697-702.|[4]Ioannidis O, et al. Effect of moxifloxacin on survival, lipid peroxidation and inflammation in immunosuppressed rats with soft tissue infection caused by Stenotrophomonas maltophilia. Microbiol Immunol. 2014 Feb;58 (2) :96-102.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
Quinolone
Citation 01
ACS Chem Biol. 2022 Jan 21;17 (1) :39-53.|Antibiotics (Basel) . 2022 Feb 1;11 (2) :192.|Antimicrob Agents Chemother. 2024 Oct 29:e0094524.|Antimicrob Agents Chemother. 2024 Oct 29:e0105124.|Antimicrob Agents Chemother. 2025 May 23:e0024925.|Antimicrob Agents Chemother. 2025 Sep 11:e0079525.|Authorea. 2025 Sep 17.|bioRxiv. 2024 Nov 06.|Infect Drug Resist. 2021 Sep 14;14:3729-3736.|Int J Pharm. 2026 Jan 5:687:126356.|J Clin Microbiol. 2025 Aug 20:e0084125.|Microbiol Spectr. 2025 May 19:e0307424.|mLife. 2025 Apr 15;4 (2) :155-168.|Molecules. 2025 Mar 9;30 (6) :1224.|Nat Commun. 2022 Mar 2;13 (1) :1116.|Nat Microbiol. 2023 Mar;8 (3) :410-423.|SSRN. 2025 Oct 14.|SSRN. 2025 Oct 20.|Water. 2025 Jun 6.|Cell Mol Life Sci. 2022 Jul 22;79 (8) :441.|Universität zu Lübeck. Klinik für Dermatologie, Allergologie und Venerologie.

Chemical Information

Moxifloxacin

Moxifloxacin is a quinolone that consists of 4-oxo-1,4-dihydroquinoline-3-carboxylic acid bearing a cyclopropyl substituent at position 1, a fluoro substitiuent at position 6, a (4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl group at position 7 and a methoxy substituent at position 8. A member of the fluoroquinolone class of antibacterial agents. It has a role as an antibacterial drug. It is a quinolone, a quinolinemonocarboxylic acid, an aromatic ether, a member of cyclopropanes, a pyrrolidinopiperidine, a quinolone antibiotic and a fluoroquinolone antibiotic. It is a conjugate base of a moxifloxacinium(1+).

CAS Number151096-09-2
PubChem CID152946
IUPAC Name7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid
Molecular FormulaC21H24FN3O4
Molecular Weight401.4
XLogP0.6
Topological Polar Surface Area82.1
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count8
Rotatable Bond Count4
Heavy Atom Count29
Formal Charge0
Complexity727
SMILES
COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
InChI
InChI=1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1
InChIKey
FABPRXSRWADJSP-MEDUHNTESA-N
Chemical Structure
2D Structure
2D structure of Moxifloxacin
CAS: 151096-09-2
CID: 152946
Formula: C21H24FN3O4
MW: 401.4
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight401.4
XLogP30.6
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count8
Rotatable Bond Count4
Exact Mass401.17508442
Monoisotopic Mass401.17508442
Topological Polar Surface Area82.1 Ų
Heavy Atom Count29
Formal Charge0
Complexity727
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Alternative Products

CatalogName
FM145387-01Moxifloxacin
RM-M160266-01Moxifloxacin Impurity 38; Moxifloxacin Impurity X
A5323-5.1Moxifloxacin HCl
M033-500MGMoxifloxacin Hydrochloride
T10987-01Decarboxy Moxifloxacin

Popular Products